Articles By Rheumnow Admin

COVID-19 Patient PSA Video Series
Dr. Jack Cush provides a series of "Patient Safety Advisories" on how patients can cope with the COVID-19 pandemic and rheumatology-related illnesses.
Read Article
An Overview of Safety Data From the RINVOQ™ (upadacitinib) Phase 3 Program
Dr. Stanley Cohen presents safety data from both the short-term controlled and long-term portions of the SELECT Phase 3 Program with RINVOQ™.
Read Article
Achieving Clinical Goals With RINVOQ™ (upadacitinib)
Dr. Alvin Wells highlights data from the SELECT clinical program and discusses treatment goals in RA.
Read Article
Key Highlights From the SELECT-COMPARE Trial
In this video, Dr. Roy Fleischmann discusses data from the SELECT-COMPARE trial with RINVOQ™ (upadacitinib).
Read Article
THE SCIENCE OF RINVOQ™ (UPADACITINIB)—A NEW JAK INHIBITOR
The US FDA has recently approved a new treatment for rheumatoid arthritis. This article features selected highlights from the prescribing information and study results of this treatment.
Read Article
Contemporary Management of RA: Is an Inflection Point at Hand?
This video features Dr. Alvin Wells, Dr. Roy Fleischmann, and Dr. Vibeke Strand discussing the goals of contemporary RA therapy, including the patient perspective, and the future of RA management.
Read Article
Biosimilars in Rheumatology
A first-of-its kind educational video series focusing on the “hot topics” in biosimilars from the perspective of leading Rheumatology experts. This educational series is presented by Sandoz, Inc.
Read Article
RheumNowLive On Demand: The History of Fibromyalgia - Dr. Fred Wolfe
A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.
Read Article
RheumNowLive On Demand: Development & Use of JAK Inhibitors - Dr. John O'Shea
A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.
Read Article
RheumNowLive On Demand: The History of Steroids - Dr. Eric Matteson
A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.
Read Article